Videos
Press Releases
17 Mar 2022
MSD’s KEYTRUDA® (pembrolizumab) Significantly Improved Disease-Free Survival (DFS) Versus Placebo as Adjuvant Therapy in Patients With Stage IB-IIIA Non-Small Cell Lung Cancer (NSCLC) Regardless of PD-L1 Expression
29 Jun 2021
PRESS RELEASE: European Organisation for Research and Treatment of Cancer (EORTC) and Pierre Fabre Partner to Address Treatment Gap for Stage 2 Melanoma Patients
4 Jun 2021
PRESS RELEASE: Sanofi partnering with leading academic cooperative groups to study amcenestrant in the adjuvant setting for patients with estrogen receptor positive breast cancer
20 Apr 2021
PRESS RELEASE: HSH Prince Albert II cedes Honorary Presidency of the EORTC Research Fund to HRH Princess Dina Mired
Latest Newsletter
News
14 May 2025
EORTC Quality of Life Conference 2025 wraps with strong call for patient-centred innovation in oncology
5 May 2025
Defining the role of pragmatic clinical trials in clinical cancer research: outcomes of a collaborative workshop hosted by the European Organisation for Research and Treatment of Cancer (EORTC)
2 May 2025
Important new results from EORTC presented at ESTRO Congress 2025
1 Apr 2025
Brain Tumour Group,Breast Cancer Group,Cutaneous Lymphoma Tumours Group,Diagnostic and Therapeutic Imaging,Endocrine Tumours Group,Gastrointestinal Tract Cancer Group,Genito-Urinary Cancers Group,Gynecological Cancer Group,Head and Neck Cancer Group,Leukemia Group,Lung Cancer Group,Lymphoma Group,Melanoma Group,News,Older Adults Council,Pathobiology Group,Pharmacology & Molecular Mechanisms Group,Quality of Life Group
New study confirms link between cancer patients’ quality of life and survival
17 Mar 2025
New Treatment for Recurrent Meningioma: LUMEN-1 Clinical Trial
6 Feb 2025
SISAQOL-IMI consortium launches final recommendations
4 Feb 2025
World Cancer Day 2025: EORTC’s commitment to older patients
11 Dec 2024
EORTC and Immunocore announce enrolment of first patient onto the only active Phase 3 adjuvant trial in uveal melanoma
21 Nov 2024
Minister F. Vandenbroucke visits EORTC Headquarters to strengthen collaborative efforts in clinical cancer research
